Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Bulletin Du Cancer|August 12, 2023
Corinne Jeanne, Isabelle Treilleux, Marie-Aude Le Frère-Belda, et al.
Annales De Pathologie|October 14, 2004
[Breast carcinoma with predominant neuroendocrine differentiation]Sophie Frachon, Dominique Pasquier, Isabelle Treilleux, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Cost-effectiveness analysis of strategies for HER2 testing of breast cancer patients in FranceMagali Morelle, Elodie Haslé, Isabelle Treilleux, et al.
Frontiers in Oncology|March 28, 2024
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challengesLaetitia Collet, Brunhilde Hanvic, Margherita Turinetto, et al.
Cancer Research|June 19, 2007
Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastasesYingshe Zhao, Richard Bachelier, Isabelle Treilleux, et al.
American Journal of Surgery|July 1, 2008
Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patientsCaroline Forgeard, Medhi Benchaib, Nicole Guerin, et al.
Breast Cancer Research and Treatment|April 23, 2011
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypesSandrine Boyault, Youenn Drouet, Claudine Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapyCharles Dumontet, Maryla Krajewska, Isabelle Treilleux, et al.
The Breast Journal|June 7, 2016
Surgical Management of Benign and Borderline Phyllodes Tumors of the BreastAmandine Moutte, Nicolas Chopin, Christelle Faure, et al.
Translational Oncology|April 17, 2016
Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast CancerHamdy A Azim, Loay Kassem, Isabelle Treilleux, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Bulletin Du Cancer|August 12, 2023
Corinne Jeanne, Isabelle Treilleux, Marie-Aude Le Frère-Belda, et al.
Annales De Pathologie|October 14, 2004
[Breast carcinoma with predominant neuroendocrine differentiation]Sophie Frachon, Dominique Pasquier, Isabelle Treilleux, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Cost-effectiveness analysis of strategies for HER2 testing of breast cancer patients in FranceMagali Morelle, Elodie Haslé, Isabelle Treilleux, et al.
Frontiers in Oncology|March 28, 2024
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challengesLaetitia Collet, Brunhilde Hanvic, Margherita Turinetto, et al.
Cancer Research|June 19, 2007
Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastasesYingshe Zhao, Richard Bachelier, Isabelle Treilleux, et al.
American Journal of Surgery|July 1, 2008
Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patientsCaroline Forgeard, Medhi Benchaib, Nicole Guerin, et al.
Breast Cancer Research and Treatment|April 23, 2011
Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypesSandrine Boyault, Youenn Drouet, Claudine Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2010
BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapyCharles Dumontet, Maryla Krajewska, Isabelle Treilleux, et al.
The Breast Journal|June 7, 2016
Surgical Management of Benign and Borderline Phyllodes Tumors of the BreastAmandine Moutte, Nicolas Chopin, Christelle Faure, et al.
Translational Oncology|April 17, 2016
Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast CancerHamdy A Azim, Loay Kassem, Isabelle Treilleux, et al.
Pageof 19